Log In
Print
BCIQ
Print
Print this Print this
 

Colobreathe, colistimethate sodium

Also known as: colomycin

  Manage Alerts
Collapse Summary General Information
Company Actavis plc
DescriptionInhaled polymyxin antibiotic
Molecular Target Lipopolysaccharide (LPS)
Mechanism of ActionCell membrane integrity disruption
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationRespiratory infection
Indication DetailsTreat cystic fibrosis (CF) patients infected with Pseudomonas aeruginosa; Treat cystic fibrosis (CF) patients with lung infection
Regulatory Designation

EU - Orphan Drug (Treat cystic fibrosis (CF) patients infected with Pseudomonas aeruginosa)

Partner

moksha8 Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today